Humoral immune responses of COVID-19 vaccines (BNT162b2, mRNA‐1273, and JNJ-78436735) in U.S. Military Health System beneficiaries
Latest Information Update: 02 Jun 2022
At a glance
- Drugs Ad26.COV2 S (Primary) ; Elasomeran (Primary) ; Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Pharmacodynamics
Most Recent Events
- 02 Jun 2022 New trial record
- 24 May 2022 Results published in the Clinical Infectious Diseases